tirzepatide weight loss study outperformed semaglutide weight-loss drug results in real world patients, shows Tirzepatide outperformed semaglutide weight-loss drug

Although Saxenda is the first generic GLP-1 to hit the US market, its sales will likely be overshadowed by next-gen drugs such as Wegovy and Zepbound.

Semaglutide suppresses hunger, but eating too little can trigger nutrient deficiencies, muscle loss, and metabolic slowdown

In these cardiovascular safety trials, in secondary or exploratory analyses, GLP-1 receptor agonists were also shown to reduce macro-albuminuria, an accepted surrogate marker for diabetic kidney disease (DKD), a condition that still represents a major unmet medical need

Formulated in MCT oil for SubQ administration, Andrenyx is available in 50 mg, 75 mg, and 100 mg doses, supplied in packs of 4 single-dose syringes